Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04271501 · ClinicalTrials.gov registry record · NA
Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions
A NA study, sponsored by Avita Medical.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04271501: Clinical Trial NA study, sponsored by Avita Medical.
NCT04271501 is a NA study that was terminated before completion, run by Avita Medical. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04271501, a NA study, was terminated before completion, sponsored by Avita Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Prospective randomized within-subject controlled feasibility study to evaluate the clinical performance of RECELL for repigmentation of stable, depigmented lesions. The trial will evaluate 50 matched, stable depigmented areas from 10 subjects.
Primary Outcome
Percent area repigmented for each study area compared to standardized reference photos by a Blinded Evaluator
Interventions
- PROCEDURE Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB)
- DEVICE RECELL 1:5 and Ultraviolet Lamp (UVB)
- DEVICE RECELL 1:10 and Ultraviolet Lamp (UVB)
- DEVICE RECELL 1:20 and Ultraviolet Lamp (UVB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-09-25 |
| Est. Completion | 2021-08-24 |
| Phase | NA |
Why NCT04271501 stopped before completion
NCT04271501 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 4 interventions - of which Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB) is the first listed.
NCT04271501 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04271501 about?
NCT04271501 is a clinical study titled "Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions". Prospective randomized within-subject controlled feasibility study to evaluate the clinical performance of RECELL for repigmentation of stable, depigmented lesions. The trial will evaluate 50 matched, stable depigmented areas from 10 subjects.
What is the current status of trial NCT04271501?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2020-09-25. Estimated completion is 2021-08-24.
What interventions are being tested in trial NCT04271501?
The interventions under investigation include: Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB) (PROCEDURE), RECELL 1:5 and Ultraviolet Lamp (UVB) (DEVICE), RECELL 1:10 and Ultraviolet Lamp (UVB) (DEVICE), RECELL 1:20 and Ultraviolet Lamp (UVB) (DEVICE).
Who is sponsoring clinical trial NCT04271501?
This trial is sponsored by Avita Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04271501's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI